ISS ESG has voluntarily issued an Environmental, Social and Governance (ESG) Corporate Rating Report to Mankind Pharma on June 3, 2025. As per the report, the Company has been assigned an overall ESG score of 38.98 (Rating: C-). The company has not verified any data on which this rating has been issued.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
